Abstract:BACKGROUND Liver organoids have recently been applied as models for liver disease and drug screening, especially when combined with liver-on-a-chip technologies. Compared to hepatocyte-like cells, primary hepatocytes have high functionality but cannot maintain their function when cultured in vitro. Mesenchymal stem cells (MSCs) enhance hepatocyte function and maintain hepatocyte metabolism when co-cultured with hepatocytes. MSCs can help induced pluripotent stem cells to generate an organoid structure via the MSC-based traction force triggered by extracellular matrix (ECM) proteins. In this study, primary hepatocytes were co-cultured with MSCs on a liver-derived ECM to generate liver organoids within a short duration. AIM To create hepatocyte organoids by co-culturing primary hepatocytes with MSCs on a porcine liver extracellular matrix (PLECM) gel. METHODS Perfusion and enzymatic hydrolysis were used to form the PLECM gel. Rat hepatocytes and human MSCs were mixed and plated on pre-solidified PLECM gel in a 48-well plate for 48 h to generate organoids. Generated organoids were evaluated through hematoxylin and eosin, periodic acid-Schiff, immuno-histological, and immunofluorescence staining, and quantitative PCR for alb, CYP450 gene markers, and urea cycle genes. Culture medium was collected to detect albumin (ALB) and urea production on days 2, 4, 6, 8, 14, and 20. RESULTS The whole porcine liver was perfused and enzymatically hydrolyzed to form a PLECM gel. The structural components and basement membrane composition of the ECM, such as collagen type I, collagen type IV, fibronectin, and laminin, were demonstrated to be retained. Through interaction of human MSCs with the liver-derived ECM, primary hepatocytes and human MSCs assembled together into a 3D construction and generated primary hepatocyte organoids for 48 h. The mRNAs of the gene alb, the CYP450 gene markers cyp1a1, cyp1a2, and cyp3a2 as well as urea cycle genes arg-1, asl, ass-1, cps-1, nags were highly expressed in hepatocyte organoids. Long-term survival of the primary hepatocyte organoids, as well as stable functionality, was demonstrated via ALB and urea production in vitro. CONCLUSION Our new method of creating primary hepatocyte organoids by co-culturing hepatocytes with MSCs on liver-derived ECM hydrogels could be used to develop models for liver disease and for drug screening.

Generation of Organoids from Mouse Extrahepatic Bile Ducts

Cell Isolation and Organoid Culture from Mouse Liver and Small Intestine

Human Bile Contains Cholangiocyte Organoid-Initiating Cells Which Expand as Functional Cholangiocytes in Non-canonical Wnt Stimulating Conditions

Highly Efficient Methods to Culture Mouse Cholangiocytes and Small Intestine Organoids

Bioengineered Tubular Biliary Organoids

Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?

Human branching cholangiocyte organoids recapitulate functional bile duct formation

Mass Generation and Long-term Expansion of Hepatobiliary Organoids from Adult Primary Human Hepatocytes

Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma

3D organoid cultivation improves the maturation and functional differentiation of cholangiocytes from human pluripotent stem cells

Generation of hepatobiliary organoids from human induced pluripotent stem cells.

Regional Differences in Human Biliary Tissues and Corresponding In Vitro –Derived Organoids

Use of human tissue stem cell-derived organoid cultures to model enterohepatic circulation

Efficient large-scale generation of functional hepatocytes from mouse embryonic stem cells grown in a rotating bioreactor with exogenous growth factors and hormones

Generation of human hepatobiliary organoids with a functional bile duct from chemically induced liver progenitor cells

Generation and metabolomic characterization of functional ductal organoids with biliary tree networks in decellularized liver scaffolds

Generation of liver bipotential organoids with a small-molecule cocktail

Creating Rat Hepatocyte Organoid As an in Vitro Model for Drug Testing.

Generation of Fibrotic Liver Organoids Using Hepatocytes, Primary Liver Sinusoidal Endothelial Cells, Hepatic Stellate Cells, and Macrophages

Three-dimensional human bile duct formation from chemically induced human liver progenitor cells

Generation of multilineage liver organoids with luminal vasculature and bile ducts from human pluripotent stem cells via modulation of Notch signaling